Editorial: Multi Target - Directed Ligands in the Treatment of Alzheimer’s Disease

Ondrej       Soukup; Jan       Korabecny

doi:10.2174/156720501609191029115310

[1] 
Mezeiova E, Chalupova K, Nepovimova E, Gorecki L, Prchal L, Malinak D, et al. Donepezil derivatives targeting amyloid-β cascade in Alzheimer’s disease. Curr Alzheimer Res  16(9): 772-800. (2019).
[2] 
Knez D, Sosič I, Pišlar A, Mitrović A, Jukič M, Kos J, et al. Biological evaluation of 8-hydroxyquinolines as multi-target directed ligands for treating Alzheimer’s disease. Curr Alzheimer Res  16(9): 801-14. (2019).
[3] 
Malek R, Refouvelet B, Benchekroun M, Iriepa I, Andrys IMR, Musilek K, et al. Synthesis and biological evaluation of novel chromone+donepezil hybrids for Alzheimer’s disease therapy. Curr Alzheimer Res  16(9): 815-20. (2019).
[4] 
Kaniakova M, Nepovimova E, Kleteckova L, Skrenkova K, Holubova K, Chrienova Z, et al. Combination of memantine and 6-chlorotacrine as novel multi-target compound against Alzheimer’s disease. Curr Alzheimer Res  16(9): 821-33. (2019).

Rights & Permissions Print Cite

Article Metrics

26

3

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/156720501609191029115310	Print ISSN 1567-2050
Publisher Name Bentham Science Publisher	Online ISSN 1875-5828

Current Alzheimer Research

Editorial: Multi Target - Directed Ligands in the Treatment of Alzheimer’s Disease

Related Journals

Related Books

Related Articles